{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T16:31:52Z","timestamp":1791304312728,"version":"4.3.1"},"reference-count":11,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IMCRJ"],"DOI":"10.2147\/imcrj.s555977","type":"journal-article","created":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T05:30:11Z","timestamp":1764221411000},"page":"1507-1511","source":"Crossref","is-referenced-by-count":3,"title":["Case Report: A Patient with Lambert-Eaton Myasthenic Syndrome Successfully Treated with Efgartigimod"],"prefix":"10.2147","volume":"Volume 18","author":[{"given":"Lizhu","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jili","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2025,11]]},"reference":[{"key":"ref1","volume-title":"StatPearls","year":"2023"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1212\/WNL.0000000000001225","volume":"84","author":"Spillane","year":"2015","journal-title":"Neurology"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1756286421997381","DOI":"10.1177\/1756286421997381","volume":"14","author":"Dalakas","year":"2021","journal-title":"Ther Adv Neurol Disord"},{"key":"ref4","unstructured":"Argenx. FDA approves new treatment for myasthenia gravis [media release]. 2021. Available from: https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-new-treatment-myasthenia-gravis. Accessed November 19, 2025."},{"key":"ref5","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/S1474-4422(21)00159-9","volume":"20","author":"Howard","year":"2021","journal-title":"Lancet Neurol"},{"key":"ref6","unstructured":"Argenx. argenx announces VYVGART\u2122 approval in Japan for the treatment of generalized myasthenia gravis [media release]. 2022. Available from: https:\/\/www.argenx.com\/. Accessed November 19, 2025."},{"key":"ref7","doi-asserted-by":"publisher","first-page":"4372","DOI":"10.1172\/JCI97911","volume":"128","author":"Ulrichts","year":"2018","journal-title":"J Clin Invest"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1229112","DOI":"10.3389\/fneur.2023.1229112","volume":"14","author":"Bhandari","year":"2023","journal-title":"Front Neurol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"28394","DOI":"10.1038\/s41598-024-79918-7","volume":"14","author":"Ma","year":"2024","journal-title":"Sci Rep"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1097\/WCO.0000000000001196","volume":"36","author":"Vanoli","year":"2023","journal-title":"Curr Opin Neurol"},{"key":"ref11","unstructured":"Jing S, Zhang Y, Lin Y, et al. Presented at the 16th international society of neuroimmunology (ISNI) congress, August 20-24, 2023."}],"container-title":["International Medical Case Reports Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/article\/download\/109328","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/article\/download\/109328","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T05:30:13Z","timestamp":1764221413000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/case-report-a-patient-with-lambert-eaton-myasthenic-syndrome-successfu-peer-reviewed-fulltext-article-IMCRJ"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":11,"URL":"https:\/\/doi.org\/10.2147\/imcrj.s555977","relation":{},"ISSN":["1179-142X"],"issn-type":[{"value":"1179-142X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11]]}}}